Millennium Management’s Inovio Pharmaceuticals INO Stock Holding History

Millennium Management’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,500	Closed	-$1.07M	–	7082
2021 Q3	$1.07M	Buy	12,500 +4,167	+50%	+$418K	﹤0.01%	4597
2021 Q2	$927K	Sell	8,333 -20,609	-71%	-$1.98M	﹤0.01%	4733
2021 Q1	$3.22M	Sell	28,942 -225	-0.8%	-$29.6K	﹤0.01%	3061
2020 Q4	$3.1M	Buy	+29,167	New	+$3.88M	﹤0.01%	2874
2020 Q3	–	Sell	-4,167	Closed	-$1.35M	–	4623
2020 Q2	$1.35M	Buy	+4,167	New	+$669K	﹤0.01%	2808

Other funds holding INO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management's INO Position: Q2 2026 in Review

Millennium Management reduced its Inovio Pharmaceuticals (INO) stake by 44% in Q2 2026, selling an estimated $729K and leaving 796,107 shares worth $876K. The position accounts for ﹤0.01% of the portfolio, ranked #4405.

Millennium Management first reported a position in INO in Q1 2014 and has held it in 38 quarters since. The position peaked at $12.6M in Q1 2020. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

Millennium Management held 796,107 shares of Inovio Pharmaceuticals worth $876K as of Q2 2026.
Millennium Management sold 614,738 Inovio Pharmaceuticals shares in Q2 2026, an estimated $729K.
Inovio Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #4405 holding.
Millennium Management first reported a position in Inovio Pharmaceuticals in Q1 2014 and has held it in 38 quarters since.
Millennium Management's Inovio Pharmaceuticals position peaked at $12.6M in Q1 2020.
102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.